Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves Sutent for rare type of pancreatic cancer

May 21, 2011Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body (metastatic).

Post navigation

← Recall of Infant and Neonatal-Sized FilterLine H Set and VitaLine H Set Sampling Lines FDA: Do not feed SimplyThick to premature infants →
Proudly powered by WordPress